tiprankstipranks
Trending News
More News >
Better Therapeutics, Inc. (BTTX)
OTHER OTC:BTTX
US Market

Better Therapeutics (BTTX) Income Statement

Compare
171 Followers

Better Therapeutics Income Statement

Last quarter (Q3 2023), Better Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Better Therapeutics's net income was $-5.86M. See Better Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 8.00K$ 18.00K
Gross Profit
$ -2.73M$ -1.62M$ -674.00K$ -880.00K
Operating Expenses
$ 35.53M$ 28.94M$ 5.65M$ 4.89M
Depreciation and Amortization
$ 53.00K$ 1.62M$ 75.00K$ 72.00K
EBITDA
$ -38.21M$ -38.68M$ -6.06M$ -5.70M
Operating Income
$ -38.26M$ -30.56M$ -6.32M$ -5.77M
Other Income/Expenses
$ -1.49M$ -9.93M$ 89.00K$ -11.00K
Pretax Income
$ -39.75M$ -40.49M$ -6.23M$ -5.78M
Net Income
$ -39.76M$ -40.34M$ -6.39M$ -5.79M
Per Share Metrics
Basic EPS
$ -1.69$ -1.71$ -1.04$ -0.25
Diluted EPS
$ -1.69$ -1.71$ -1.04$ -0.25
Weighted Average Shares Outstanding
23.56M 23.60M 7.56M 23.60M
Weighted Average Shares Outstanding (Diluted)
23.56M 23.60M 7.56M 23.60M
Currency in USD

Better Therapeutics Earnings and Revenue History